Merli, Pietro
 Distribuzione geografica
Continente #
AS - Asia 2.222
NA - Nord America 1.725
SA - Sud America 615
EU - Europa 459
Continente sconosciuto - Info sul continente non disponibili 147
AF - Africa 87
OC - Oceania 2
Totale 5.257
Nazione #
US - Stati Uniti d'America 1.563
SG - Singapore 660
BD - Bangladesh 533
BR - Brasile 465
CN - Cina 386
IT - Italia 334
HK - Hong Kong 238
VN - Vietnam 105
IN - India 77
CA - Canada 64
AR - Argentina 61
MX - Messico 56
ID - Indonesia 30
MY - Malesia 24
IQ - Iraq 23
TR - Turchia 23
VE - Venezuela 22
GB - Regno Unito 21
PK - Pakistan 20
CO - Colombia 19
SA - Arabia Saudita 19
UZ - Uzbekistan 19
MA - Marocco 18
ZA - Sudafrica 18
EC - Ecuador 17
PH - Filippine 14
FR - Francia 13
NL - Olanda 12
PY - Paraguay 11
DE - Germania 10
TN - Tunisia 10
JM - Giamaica 9
RU - Federazione Russa 9
UA - Ucraina 9
EG - Egitto 8
CL - Cile 7
ES - Italia 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
KE - Kenya 6
NP - Nepal 6
PE - Perù 6
TT - Trinidad e Tobago 6
BB - Barbados 5
IE - Irlanda 5
PT - Portogallo 5
TH - Thailandia 5
AZ - Azerbaigian 4
HN - Honduras 4
LY - Libia 4
RS - Serbia 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
JO - Giordania 3
KR - Corea 3
LC - Santa Lucia 3
OM - Oman 3
PL - Polonia 3
PS - Palestinian Territory 3
QA - Qatar 3
SE - Svezia 3
UY - Uruguay 3
AO - Angola 2
AU - Australia 2
BJ - Benin 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
FI - Finlandia 2
HR - Croazia 2
IL - Israele 2
JP - Giappone 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
MG - Madagascar 2
MU - Mauritius 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
SV - El Salvador 2
AL - Albania 1
BE - Belgio 1
BG - Bulgaria 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IR - Iran 1
Totale 5.097
Città #
San Jose 692
Singapore 347
Hong Kong 231
Beijing 203
Ashburn 202
Council Bluffs 156
Rome 63
Santa Clara 59
Ho Chi Minh City 48
Mexico City 39
São Paulo 33
Milan 31
New York 30
Los Angeles 29
Hanoi 24
Buffalo 20
Naples 20
Rio de Janeiro 19
Tashkent 17
Toronto 14
Belo Horizonte 13
Brasília 13
Dhaka 13
Kuala Lumpur 12
Medellín 10
Baghdad 9
Dallas 9
Turin 9
Bari 8
Casablanca 8
Curitiba 8
Shanghai 8
Charlotte 7
Chicago 7
Florence 7
Istanbul 7
Jeddah 7
Montreal 7
Valencia 7
Asunción 6
Bologna 6
Buenos Aires 6
Kingston 6
Lahore 6
Pasadena 6
Philadelphia 6
Salvador 6
Xi'an 6
Biên Hòa 5
Bridgetown 5
Cairo 5
Caracas 5
Faisalabad 5
Genoa 5
Guayaquil 5
Johannesburg 5
Juiz de Fora 5
Kathmandu 5
Manaus 5
Nairobi 5
Pelotas 5
Porto Alegre 5
Quito 5
Rabat 5
The Bronx 5
Ahmedabad 4
Belgrade 4
Belém 4
Bengaluru 4
Campinas 4
Dammam 4
Delhi 4
Detroit 4
Dubai 4
Joinville 4
Medina 4
Mississauga 4
Orem 4
Ribeirão Preto 4
San Juan 4
St Louis 4
Wellingborough 4
Winnipeg 4
Amsterdam 3
Atlanta 3
Bangkok 3
Betim 3
Brooklyn 3
Cape Town 3
Carapicuíba 3
Castries 3
Caxias do Sul 3
Changsha 3
Ciudad del Este 3
Contagem 3
Doha 3
Dublin 3
Durban 3
Fortaleza 3
Guangzhou 3
Totale 2.708
Nome #
Expansion of CD4(dim)CD(8+) T cells characterizes macrophage activation syndrome and other secondary HLH 218
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 127
TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis 100
Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT 92
Oral manifestations and complications in childhood acute myeloid leukemia 79
CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia 78
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD 78
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis 76
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature 72
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 69
Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients 63
Outcome of children with acute leukemia given HLA-haploidentical HSCT after alpha beta T-cell and B-cell depletion 55
A Day 14 Endpoint for Acute GVHD Clinical Trials 54
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 51
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation 51
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells 50
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children 48
Effectiveness of emicizumab in preventing life-threatening bleeding complications in type 3 von Willebrand disease with inhibitors: A paediatric report 48
Fecal microbiota transplantation for decolonization from multidrug-resistant bacteria in pediatric allogeneic hematopoietic stem cell transplantation recipients: a retrospective real-word data study 47
Immunoselection techniques in hematopoietic stem cell transplantation 46
Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes 45
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform 44
Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy 44
Allogeneic, donor-derived, second-generation, CD19-CAR-T cell for the treatment of pediatric relapsed/refractory BCP-ALL 44
Novel Compound Heterozygous Mutations in IL-7 Receptor alpha Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment 44
Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia 44
TCR alpha beta/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders 44
Hematopoietic stem cell transplantation in neuromyelitis optica-spectrum disorders (NMO-SD): State-of-the-art and future perspectives 44
Preservation of antigen-specific Functions of alpha beta T cells and B cells removed from hematopoietic stem cell Transplants suggests Their Use as an alternative cell source for advanced Manipulation and adoptiveimmunotherapy Immunotheraphy 44
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with alpha-1-antitrypsin 44
Direct Involvement of Cranial Nerve V at Diagnosis in Patients With Diffuse Intrinsic Pontine Glioma: A Potential Magnetic Resonance Predictor of Short-Term Survival 43
Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia 43
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 43
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group 42
At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies 42
Immune Modulation Properties of Zoledronic Acid on TcR gamma delta T-Lymphocytes After TcR alpha beta/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia 42
Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience 41
Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation 41
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study 41
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 41
Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL) 41
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification 40
Zoledronic acid boosts gamma delta T-cell activity in children receiving alpha beta(+) T and CD19(+) cell-depleted grafts from an HLA-haplo-identical donor 40
Fecal microbiota transplant in two ulcerative colitis pediatric cases: Gut microbiota and clinical course correlations 40
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome 39
Use of ruxolitinib to control graft-versus-host-like disease in Omenn syndrome and successfully bridging to HSCT 39
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease 38
B-cell depleting immunotherapies: therapeutic opportunities and toxicities 38
Agenesis of Internal Carotid Artery and Hypopituitarism: Case Report and Review of Literature 38
Safety of Nirmatrelvir-Ritonavir Administration in Children With Immunodeficiency and/or Comorbidities With SARS-CoV-2 Infection: A Retrospective Clinical Report 37
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial 37
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease 37
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia 37
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy 37
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies 37
Natural killer cells in the treatment of high-risk acute leukaemia 37
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 36
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis 36
Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation 36
NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart 36
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 36
Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia 36
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol 36
Italian pediatric intensive care units admitting critically ill cancer children: results from a national survey 36
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications 35
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 35
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management 35
Nasal Disease and Asthma 35
Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement 34
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD 34
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant 34
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 34
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III 34
Case Report: Massive Intestinal Pneumatosis and Pneumoretroperitoneum Following Hematopoietic Stem Cell Transplantation in a 2-Year-Old Child 33
Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors 33
TCR alpha beta/CD19 depleted hematopoietic stem cell transplantation from haploidentical donors: dissecting the GvL/GvHD conundrum 33
alpha beta T- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes 33
T cell therapy for nasopharyngeal carcinoma 33
Case Report: Trichosporon japonicum Fungemia in a Pediatric Patient With Refractory Acute B Cell Lymphoblastic Leukemia 33
Phenotypic and functional characterization of nk cells in αβt-cell and b-cell depleted haplo-hsct to cure pediatric patients with acute leukemia 32
Reconstitution of multifunctional CD56(low)CD16(low) natural killer cell subset in children with acute leukemia given / T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation 32
Truncated form of human CD19 antigen as a suicide gene to control T-cell alloreactivity: ΔCD19 32
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 32
Non-response to vaccines: still an enigma? B-cell transcription factor POU2F2/OCT2 is a potential candidate 32
Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant? 32
Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection 31
QuantiFERON-TB Gold can help clinicians in the diagnosis of haemophagocytic lymphohistiocytosis 31
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group 31
Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis 31
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation 30
The utility of biomarkers in acute GVHD prognostication 30
The changing role of stem cell transplantation in childhood 30
MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors 30
Eltrombopag for treatment of thrombocytopenia-associated disorders 30
Role of interferon-gamma in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation 29
GATA2 and marrow failure 29
Strategies To Increase CAR T-Cell Safety and to Prevent Epitope Masking In CAR plus B-Cell Leukemia Blasts 29
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients 29
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia 28
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease 27
Totale 4.407
Categoria #
all - tutte 22.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025905 0 0 0 122 21 6 67 123 35 25 218 288
2025/20263.816 165 17 235 203 340 164 297 159 740 435 498 563
2026/2027536 129 107 300 0 0 0 0 0 0 0 0 0
Totale 5.257